XML 30 R17.htm IDEA: XBRL DOCUMENT
v3.8.0.1

11. Segment Information | 9 Months Ended
--- | ---
Sep. 30, 2017
Segment Reporting [Abstract] |
Segment Information | SEGMENT INFORMATION Information regarding industry segments for the three months ended September 30, 2017 and 2016 is as follows (in millions):
|  | Life Science |  | Clinical Diagnostics |  | Other Operations
Segment net sales | 2017 | $ | 193.6 |  |  | $ | 338.0 |  |  | $ | 3.4 |
| 2016 | $ | 178.1 |  |  | $ | 327.1 |  |  | $ | 3.5 |
Segment net profit (loss) | 2017 | $ | 7.8 |  |  | $ | 35.4 |  |  | $ | 0.2 |
| 2016 | $ | (4.4 | ) |  | $ | 28.4 |  |  | $ | 0.3 |
Information regarding industry segments for the nine months ended September 30, 2017 and 2016 is as follows (in millions):
|  | Life Science |  | Clinical Diagnostics |  | Other Operations
Segment net sales | 2017 | $ | 547.3 |  |  | $ | 982.3 |  |  | $ | 10.1 |
| 2016 | $ | 523.9 |  |  | $ | 962.5 |  |  | $ | 10.3 |
Segment net (loss) profit | 2017 | $ | (34.0 | ) |  | $ | 94.3 |  |  | $ | 0.6 |
| 2016 | $ | (12.9 | ) |  | $ | 77.0 |  |  | $ | 0.5 |
Segment results are presented in the same manner as we present our operations internally to make operating decisions and assess performance. Net corporate operating, interest and other expense for segment results consists of receipts and expenditures that are not the primary responsibility of segment operating management and therefore are not allocated to the segments for performance assessment by our chief operating decision maker. Interest expense is charged to segments based on the carrying amount of inventory and receivables employed by that segment. During the second quarter of 2017, our Clinical Diagnostics segment had an asset purchase for an early stage device for $7.5 million that was recorded in Research and development expense. See Note 13 for a discussion of restructuring costs. The following reconciles total segment profit to consolidated income before taxes (in millions):
| Three Months Ended |  | Nine Months Ended
| September 30, |  | September 30,
| 2017 |  | 2016 |  | 2017 |  | 2016
Total segment profit | $ | 43.4 |  |  | $ | 24.3 |  |  | $ | 60.9 |  |  | $ | 64.6 |
Foreign currency exchange losses, net | (3.4 | ) |  | (1.2 | ) |  | (7.7 | ) |  | (3.6 | )
Net corporate operating, interest and other expense not allocated to segments | (2.5 | ) |  | (1.8 | ) |  | (7.7 | ) |  | (5.1 | )
Other income (expense), net | 1.4 |  |  | 1.4 |  |  | 14.6 |  |  | 13.8 |
Consolidated income before income taxes | $ | 38.9 |  |  | $ | 22.7 |  |  | $ | 60.1 |  |  | $ | 69.7 |

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration